Hallmarks of Cancer: New Approaches and Treatment Strategies
A special issue of International Journal of Translational Medicine (ISSN 2673-8937).
Deadline for manuscript submissions: 30 April 2026 | Viewed by 83
Special Issue Editors
Interests: leukemia; hematology; oncology; human genetics; acute leukemia; gene expression
Interests: pharmacokinetics, bioavailability/bioequivalence and clinical pharmacology; oncology
Special Issue Information
Dear Colleagues,
This Special Issue aims to explore the latest research and advancements related to the fundamental characteristics that define cancer, known as the Hallmarks of Cancer. These hallmarks include capabilities such as sustaining proliferative signalling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis. The goal is to present innovative studies that shed light on how these hallmarks contribute to cancer development and progression. Additionally, the Special Issue seeks to highlight novel therapeutic strategies aimed at targeting these hallmarks to improve cancer treatment outcomes. Potential authors are encouraged to submit research articles, reviews, and perspectives that deepen our understanding of these biological features and explore new avenues for intervention. Overall, this Special Issue aspires to serve as a comprehensive resource for researchers and clinicians interested in the molecular mechanisms of cancer and the development of targeted therapies.
Prof. Dr. Caroline De Fátima Aquino Moreira-Nunes
Dr. Maria Elisabete Amaral De Moraes
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Translational Medicine is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- hallmarks
- targeting
- tumour
- metastasis
- angiogenesis
- immune evasion
- cell proliferation
- genetic mutations
- therapeutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
